STRIDES PHARMA SCIENCE LIMITED — Regulatory Filings 2021

Apr 12, 2021

==> picture [136 x 45] intentionally omitted <==

April 12, 2021

BSE Limited

Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001 Scrip code: 532531

The National Stock Exchange of India Limited Exchange Plaza, Bandra-Kurla Complex Bandra (E) Mumbai - 400 051 Scrip code: STAR

Dear Sirs,

• Sub: Intimation pursuant to Regulation 31A of SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations)

• Ref: Strides’ intimation to stock exchanges dated October 1, 2020 regarding reclassification request received from SeQuent Scientific Limited (SeQuent) for reclassification from ‘Promoter Group’ to ‘Public’ Category;

Strides’ intimation to stock exchanges dated October 29, 2020 regarding Board approval for such reclassification; and

Strides’ intimation to stock exchanges dated March 17, 2021 regarding Members’ approval for such reclassification.

Further to the above, we wish to inform you that the Company has submitted an application with your office today i.e., on April 12, 2021, seeking your approval for the reclassification of SeQuent Scientific Limited from ‘Promoter Group’ to ‘Public’ category under Regulation 31A of SEBI Listing Regulations.

Request you to kindly take the same on record and oblige.

Thanks & Regards,

For Strides Pharma Science Limited

==> picture [115 x 52] intentionally omitted <==

Manjula Ramamurthy Company Secretary

==> picture [85 x 82] intentionally omitted <==

==> picture [479 x 53] intentionally omitted <==